首页> 美国卫生研究院文献>Annals of Thoracic and Cardiovascular Surgery >Communication Site Ligation and Polyglycolic Acid Sheet Use for the Treatment of Hydrothorax in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis
【2h】

Communication Site Ligation and Polyglycolic Acid Sheet Use for the Treatment of Hydrothorax in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

机译:交流位点结扎术和聚乙醇酸片用于连续性非卧床腹膜透析患者胸腔积水的治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction: Hydrothorax due to pleuroperitoneal communication (PPC) can occur in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). We report our experiences of the safety and efficacy of the treatment of four patients with a novel video- assisted thoracoscopy method.Methods: Single-port video-assisted thoracoscopic surgery (VATS) was performed with a mini-thoracotomy of 5 cm in length. The PPC site was identified on the diaphragm and ligated using an endoscopic loop. The diaphragm was then covered using a polyglycolic acid (PGA) sheet, over which adhesive chemicals (OK432 and tetracycline) were sprayed.Results: We assessed the efficacy of our approach in four patients (one female and three males) aged 42–74 years (mean: 62.0 years). The hydrothoraxes were right sided in all the patients. The mean operation and postoperative drainage times were 92.5 min and 3.0 days, respectively. The hydrothoraxes did not recur in any patient during follow-up periods of 8–46 months.Conclusion: Our suture- and staple-free technique is not only easy to perform but also appears to be safe and effective for the management of hydrothorax in patients receiving CAPD. Larger scale studies are now indicated.
机译:简介:进行连续非卧床腹膜透析(CAPD)的患者可能会由于胸膜腹膜沟通(PPC)发生胸膜积水。我们报告了我们使用新颖的视频辅助胸腔镜方法治疗四例患者的安全性和有效性的经验。方法:单口视频辅助胸腔镜手术(VATS)的长度为5 cm,行迷你开胸术。 PPC部位在隔膜上被识别,并使用内窥镜环结扎。然后用聚乙醇酸(PGA)膜覆盖隔膜,在其上喷洒粘性化学药品(OK432和四环素)。结果:我们评估了我们的方法对42岁至74岁的四名患者(一名女性和三名男性)的疗效(平均:62.0年)。所有患者的胸腔均为右侧。平均手术时间和术后引流时间分别为92.5分钟和3.0天。在8至46个月的随访期间,任何患者均未再发生胸膜积水。结论:我们的无缝合和无钉技术不仅易于操作,而且对于治疗患者的胸膜积水是安全有效的接受CAPD。现在指出了更大规模的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号